PUBLICATIONS · 36564047
Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adults.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2023 Apr 27
- First author
- Harker-Murray P
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Blood. 2023 Apr 27;141(17):2037-2038. doi: 10.1182/blood.2022019339.
- note
- Source null
- related pmid
- 37103949
- relationship
- Comment in
Authors and identifiers
- name
- Harker-Murray P
- type
- Author
- name
- Mauz-Körholz C
- type
- Author
- name
- Leblanc T
- type
- Author
- name
- Mascarin M
- type
- Author
- name
- Michel G
- type
- Author
- name
- Cooper S
- type
- Author
- name
- Beishuizen A
- type
- Author
- name
- Leger KJ
- type
- Author
- name
- Amoroso L
- type
- Author
- name
- Buffardi S
- type
- Author
- name
- Rigaud C
- type
- Author
- name
- Hoppe BS
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Harker-Murray P
- type
- Author
- name
- Mauz-Körholz C
- type
- Author
- name
- Leblanc T
- type
- Author
- name
- Mascarin M
- type
- Author
- name
- Michel G
- type
- Author
- name
- Cooper S
- type
- Author
- name
- Beishuizen A
- type
- Author
- name
- Leger KJ
- type
- Author
- name
- Amoroso L
- type
- Author
- name
- Buffardi S
- type
- Author
- name
- Rigaud C
- type
- Author
- name
- Hoppe BS
- type
- Author
- bibliography ids
- nci-bib-9e86473af32aee00c8114751
- book metadata
- content sha256
- a19e0aea2c232d67f99f92054ac851a451acbcf722359c7c922206a6bb1357fd
- document type
- citation
- dois
- 10.1182/blood.2022017118
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:36564047
- immutable id
- pubmed:36564047@a19e0aea2c232d67f99f92054ac851a451acbcf722359c7c922206a6bb1357fd
- journal
- abbreviation
- Blood
- issn electronic
- 1528-0020
- issn print
- 0006-4971
- issue
- 17
- name
- Blood
- nlm unique id
- 7603509
- pages
- 2075-2084
- volume
- 141
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Blood. 2023 Apr 27;141(17):2037-2038. doi: 10.1182/blood.2022019339.
- note
- Source null
- related pmid
- 37103949
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 36564047
- provenance
- batch id
- d370e99271168e8a8a13
- provider
- NCBI PubMed ESummary
- record sha256
- 213ed9fbc50b6063aa75696e6214721291c01435cbf3d0bcf1e96d332b1ee5de
- response sha256
- f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
- retrieved at
- 2026-09-09T23:48:13.005737+00:00
- publication date
- display
- 2023 Apr 27
- precision
- day
- year
- 2023
- publication types
- Clinical Trial
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adults.
Preserved source evidence · Not medical advice
Triangle